These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7537541)

  • 1. Complement in serum and dialysate in children on continuous ambulatory peritoneal dialysis.
    Reddingius RE; Schröder CH; Daha MR; Willems HL; Koster AM; Monnens LA
    Perit Dial Int; 1995; 15(1):49-53. PubMed ID: 7537541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serum complement system in children on continuous ambulatory peritoneal dialysis.
    Reddingius RE; Schröder CH; Daha MR; Monnens LA
    Perit Dial Int; 1993; 13(3):214-8. PubMed ID: 8369352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients.
    Goedde M; Sitter T; Schiffl H; Bechtel U; Schramm W; Spannagl M
    Perit Dial Int; 1997; 17(2):162-6. PubMed ID: 9159837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icodextrin and intraperitoneal inflammation.
    Moriishi M; Kawanishi H
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal study of proteins in plasma and dialysate during continuous ambulatory peritoneal dialysis (CAPD).
    Young GA; Taylor A; Kendall S; Brownjohn AM
    Perit Dial Int; 1990; 10(4):257-61. PubMed ID: 2096924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal transport kinetics of proteins in children on chronic peritoneal dialysis.
    Arbeiter K; Stemberger R; Greenbaum L; Mueller T; Konstantin A; Herkner K; Aufricht C
    Perit Dial Int; 2003; 23(2):162-8. PubMed ID: 12713084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal protein loss in children with nephrotic syndrome during peritoneal dialysis.
    de Boer AW; Schröder CH; Reddingius RE; Willems HL; Monnens LA
    Nephrol Dial Transplant; 1998 Sep; 13(9):2348-50. PubMed ID: 9761521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis.
    Kabanda A; Goffin E; Bernard A; Lauwerys R; van Ypersele de Strihou C
    Kidney Int; 1995 Dec; 48(6):1946-52. PubMed ID: 8587256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
    Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
    Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients.
    Tsujimoto Y; Shoji T; Tabata T; Morita A; Emoto M; Nishizawa Y; Morii H
    Am J Kidney Dis; 1999 Nov; 34(5):832-8. PubMed ID: 10561138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration.
    Heimbürger O; Wang T; Lönnqvist F; Stenvinkel P
    Nephrol Dial Transplant; 1999 Mar; 14(3):723-7. PubMed ID: 10193827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD.
    Zemel D; Imholz AL; de Waart DR; Dinkla C; Struijk DG; Krediet RT
    Kidney Int; 1994 Nov; 46(5):1422-30. PubMed ID: 7853803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD.
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1997 Jun; 51(6):1885-92. PubMed ID: 9186879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
    Smit W; de Waart DR; Struijk DG; Krediet RT
    Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of peritoneal fluid handling in children on continuous ambulatory peritoneal dialysis using autologous hemoglobin.
    Reddingius RE; Schröder CH; Willems HL; van den Brandt FC; Koomen GC; Krediet RT; Monnens LA
    Perit Dial Int; 1994; 14(1):42-7. PubMed ID: 8312413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
    Weinreich T; Ritz E; Passlick-Deetjen J
    Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calculation of 6-hour D/P creatinine ratio from the 4-hour peritoneal equilibration test. The effect of dwell duration on the results.
    Mehrotra R; Khanna R; Yang TC; Kathuria P; Moore HL; Prowant BF; Nolph KD; Twardowski ZJ
    Perit Dial Int; 1997; 17(3):273-8. PubMed ID: 9237289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal hyaluronan production in stable continuous ambulatory peritoneal dialysis patients.
    Yamagata K; Tomida C; Koyama A
    Perit Dial Int; 1999; 19(2):131-7. PubMed ID: 10357183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.